These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27901482)

  • 21. PARP1 regulates the protein stability and proapoptotic function of HIPK2.
    Choi JR; Shin KS; Choi CY; Kang SJ
    Cell Death Dis; 2016 Oct; 7(10):e2438. PubMed ID: 27787517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
    Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
    Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.
    Nardinocchi L; Puca R; Guidolin D; Belloni AS; Bossi G; Michiels C; Sacchi A; Onisto M; D'Orazi G
    Biochim Biophys Acta; 2009 Feb; 1793(2):368-77. PubMed ID: 19046997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.
    He Y; Roos WP; Wu Q; Hofmann TG; Kaina B
    Mol Cancer Res; 2019 May; 17(5):1129-1141. PubMed ID: 30796178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
    Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
    Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
    Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
    Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
    EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity.
    D'Orazi G; Garufi A; Cirone M
    IUBMB Life; 2020 Aug; 72(8):1634-1639. PubMed ID: 32593231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.
    Cecchinelli B; Lavra L; Rinaldo C; Iacovelli S; Gurtner A; Gasbarri A; Ulivieri A; Del Prete F; Trovato M; Piaggio G; Bartolazzi A; Soddu S; Sciacchitano S
    Mol Cell Biol; 2006 Jun; 26(12):4746-57. PubMed ID: 16738336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response.
    Calzado MA; De La Vega L; Munoz E; Schmitz ML
    Cell Cycle; 2009 Jun; 8(11):1659-64. PubMed ID: 19448429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
    Dauth I; Krüger J; Hofmann TG
    Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer.
    D'Orazi G; Rinaldo C; Soddu S
    J Exp Clin Cancer Res; 2012 Aug; 31(1):63. PubMed ID: 22889244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoregulatory control of the p53 response by Siah-1L-mediated HIPK2 degradation.
    Calzado MA; de la Vega L; Muñoz E; Schmitz ML
    Biol Chem; 2009 Oct; 390(10):1079-83. PubMed ID: 19642869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
    D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
    Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation.
    Garufi A; Pistritto G; Ceci C; Di Renzo L; Santarelli R; Faggioni A; Cirone M; D'Orazi G
    PLoS One; 2012; 7(11):e48342. PubMed ID: 23144866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.
    Pierantoni GM; Rinaldo C; Mottolese M; Di Benedetto A; Esposito F; Soddu S; Fusco A
    J Clin Invest; 2007 Mar; 117(3):693-702. PubMed ID: 17290307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response.
    Calzado MA; de la Vega L; Möller A; Bowtell DD; Schmitz ML
    Nat Cell Biol; 2009 Jan; 11(1):85-91. PubMed ID: 19043406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival.
    Lanni C; Nardinocchi L; Puca R; Stanga S; Uberti D; Memo M; Govoni S; D'Orazi G; Racchi M
    PLoS One; 2010 Apr; 5(4):e10171. PubMed ID: 20418953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.